Sign In
Buy CCXI
$13.86
-0.140 (-1.00%)
At Close: Jul 31, 2026
ChemoCentryx to Hold Third Quarter 2020 Financial Results Conference Call on Monday, November 9, 2020
08:30am, Monday, 02'nd Nov 2020
MOUNTAIN VIEW, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's third quarter 2020 financial results will be released after market close
-- Avacopan demonstrates statistically significant dose-dependent improvement in HiSCR (Hidradenitis Suppurativa Clinical Response) vs. placebo in pre-specified Hurley Stage III (severe HS) patients a
Stock Traders Purchase Large Volume of Call Options on ChemoCentryx (NASDAQ:CCXI)
02:00am, Sunday, 11'th Oct 2020
ChemoCentryx Inc (NASDAQ:CCXI) was the target of some unusual options trading on Friday. Investors purchased 3,359 call options on the company. This represents an increase of approximately 230% compar
Exane Derivatives Purchases 182 Shares of ChemoCentryx Inc (NASDAQ:CCXI)
08:10am, Thursday, 08'th Oct 2020
Exane Derivatives boosted its stake in ChemoCentryx Inc (NASDAQ:CCXI) by 11.3% during the 3rd quarter, HoldingsChannel reports. The fund owned 1,794 shares of the biopharmaceutical company’s stock a
Principal Financial Group Inc. Buys 5,740 Shares of ChemoCentryx Inc (NASDAQ:CCXI)
07:26am, Thursday, 08'th Oct 2020
Principal Financial Group Inc. lifted its holdings in shares of ChemoCentryx Inc (NASDAQ:CCXI) by 40.4% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 19,
ChemoCentryx Inc (NASDAQ:CCXI) Expected to Announce Quarterly Sales of $12.86 Million
06:20am, Friday, 02'nd Oct 2020
Analysts expect ChemoCentryx Inc (NASDAQ:CCXI) to report sales of $12.86 million for the current quarter, according to Zacks Investment Research. Five analysts have made estimates for ChemoCentryx’s
7,600 Shares in ChemoCentryx Inc (NASDAQ:CCXI) Acquired by Handelsbanken Fonder AB
08:22am, Monday, 28'th Sep 2020
Handelsbanken Fonder AB bought a new position in shares of ChemoCentryx Inc (NASDAQ:CCXI) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Co
California State Teachers Retirement System Boosts Stock Holdings in ChemoCentryx Inc (NASDAQ:CCXI)
08:40am, Friday, 25'th Sep 2020
California State Teachers Retirement System lifted its stake in shares of ChemoCentryx Inc (NASDAQ:CCXI) by 8.3% during the second quarter, Holdings Channel reports. The fund owned 67,060 shares of th
Public Employees Retirement System of Ohio Decreases Position in ChemoCentryx Inc (NASDAQ:CCXI)
09:54am, Wednesday, 23'rd Sep 2020
Public Employees Retirement System of Ohio cut its position in ChemoCentryx Inc (NASDAQ:CCXI) by 36.0% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 27,655 s
Global Hidradenitis Suppurativa (HS) Market Insights, Epidemiology and Market Forecasts, 2017-2019 & 2020-2030 - ResearchAndMarkets.com
12:00am, Wednesday, 23'rd Sep 2020
The
Bank of New York Mellon Corp Has $12.19 Million Holdings in ChemoCentryx Inc (NASDAQ:CCXI)
04:42am, Thursday, 17'th Sep 2020
Bank of New York Mellon Corp grew its holdings in ChemoCentryx Inc (NASDAQ:CCXI) by 5.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC
ChemoCentryx Inc (CCXI) Q2 2020 Earnings Call Transcript
08:31pm, Tuesday, 11'th Aug 2020
CCXI earnings call for the period ending June 30, 2020.
Tencent’s China Literature Crashes to $465 Million Loss
02:00pm, Tuesday, 11'th Aug 2020
China Literature, which is both China’s leading online bookstore and owner of one of the country’s top TV producers, swung from profits of $55 million a year ago to net losses of $465 million in t
Analysts Are Bullish on These Healthcare Stocks: ChemoCentryx (CCXI), ICU Medical (ICUI) - Markets
12:30pm, Tuesday, 11'th Aug 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ChemoCentryx (CCXI
ChemoCentryx (CCXI) Q2 Earnings and Revenues Surpass Estimates
09:45pm, Monday, 10'th Aug 2020
ChemoCentryx (CCXI) delivered earnings and revenue surprises of 185.29% and 494.95%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
